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Abstract
Background: The 5-year survival rate in patients with gastric cancer is still poor, and lymph node
metastasis is considered one of the most important prognostic factors. However, there are
controversies in the classification of lymph node metastasis in gastric cancer. This study was carried
out to investigate whether the metastatic lymph node ratio is a reliable classification of lymph node
metastasis in gastric cancer in Chinese.
Methods: 224 cases with gastric cancer with more than D1 dissection were retrospectively
reviewed. The association between the total number of resected lymph nodes and the number of
metastatic lymph nodes was determined. The prognostic value of the metastastic node ratio,
defined as the ratio of the number of metastatic lymph nodes over the total number of resected
lymph nodes, and the pN classification was assessed.
Results: The number of metastatic lymph node increased with the number of total resected lymph
nodes. A Cox regression revealed that the metastatic node ratio, the number of metastatic nodes,
histological type, and histological growth pattern independently influenced prognosis. The 5-year
survival rates were 78%, 61%, 25%, 0% in cases with a metastastic node ratio of 0%, > 0% but <
40%, 40–80%, > 80%, respectively (P < 0.001), and were 78%, 62%, 38%, 0% in cases with gastric
cancer histologically classified as pN0, pN1, pN2, pN3, respectively (P < 0.001).
Conclusion: The metastatic lymph node ratio is a simple and useful independent prognostic factor.
It may obviate possible confounding factors that are related to stage migration, and should be
considered as an important component in the lymph node category.
Background
Gastric cancer remains a major cause of cancer death, and
the 5-year survival rate in patients with gastric cancer is
still poor despite improved survival due to early detection,
rational lymphadenectomy and several therapeutic
modalities [1]. Lymph node metastasis is considered one
of the most important prognostic factors, and accurate
categorization of lymph node metastasis or optimization
of pN category is fundamentally critical for decision mak-
ing of the subsequent therapies after surgery [2-4]. Thus,
the rational categorization of resected lymph nodes will
help further improve therapeutic efficacy [1].
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However, there are controversies in the classification of
lymph node metastasis in gastric cancer. In Japan, the clas-
sification of lymph node metastasis is based on the ana-
tomical station of metastatic lymph nodes [5]. However,
in Western countries, it is classified by the number of met-
astatic regional lymph nodes according to the tumor node
metastasis (TNM) staging categories established by the
International Union against Cancer (UICC) [6]. Previ-
ously, it has been shown that lymph node metastasis is a
significant prognostic factor in gastric cancer [7,8]. Some
previous studies have demonstrated that the total number
of metastatic lymph nodes is a reliable indicator as a prog-
nostic factor than anatomical lymphatic spread [9-12].
Moreover, a few recent studies have suggested that the
metastatic lymph node ratio is a more reliable prognostic
factor [13-17]. However, the clinical values of these path-
ological parameters have not been fully verified. In addi-
tion, most studies on the prognostic significance of the
number and ratio of metastatic lymph nodes in gastric
cancer were carried out in western countries, and relevant
data are virtually lacking in China. Therefore, the aim of
this retrospective study was to investigate whether the
metastatic lymph node ratio is a reliable classification of
lymph node metastasis in gastric cancer in Chinese.
Methods
Patients
425 cases with gastric cancer (36 early and 389 advanced)
were treated at the Department of Oncology, First Affili-
ated Hospital of China Medical University, Shenyang,
China, between 1997 and 2002.
The inclusion criteria for this study included: 1), patients
who received curative resection; 2), patients who under-
went a lymph node dissection beyond limited (D1) dis-
section, i.e. D1 dissection + dissection of lymph nodes
along the left gastric artery, D1 dissection + dissection of
lymph nodes along the common hepatic artery, D1 dis-
section + dissection of lymph nodes along the celiac
artery, extended (D2) dissection, or superextended (D3)
dissection; and 3), patients in whom more than 15 lymph
nodes were resected and pathologically examined [18].
The exclusion criteria included 1), patients who received a
palliative operation; 2), patients who underwent a D1
lymph node dissection; 3), patients who had metastatic
lymph nodes in retropancreatic, mesenteric, duodenohe-
patic ligament, or para-aortic lymph node metastasis were
excluded; and 4), patients with liver metastasis and peri-
toneal dissemination.
Based on the inclusion and exclusion criteria, 201 patients
were excluded from the Study; 12 of the 36 cases with
early gastric cancer and 98 cases with advanced gastric
cancer received D1 lymph node dissection, and/or had
less than 15 lymph nodes resected for pathologically
examination. 34 patients had metastatic lymph nodes in
retropancreatic, mesenteric, duodenohepatic ligament, or
para-aortic lymph node metastasis. 57 cases (including
those with liver metastasis and peritoneal dissemination)
received a palliative operation. Therefore, a total of 224
patients with gastric cancer were included in the study.
Their demographic and clinical characteristics are shown
in Table 1.
The study protocol was approved by the Ethics Committee
of China Medical University.
Table 1: Demographic data and clinical and pathological 
characteristics of patients
Characteristics Number 
of cases
Sex Male 153
Female 71
Age (years old) ≤ 60 114
> 60 110
Tumor number Single 208
Multitude 16
Location of tumor U (upper third stomach) 9
M (middle third stomach) 41
L (lower third stomach) 174
Maximum tumor 
diameter (cm)
≤ 22 8
2–4 85
> 4 111
pT category pT1 34
pT2 128
pT3 59
pT4 3
Histological type G1 (well differentiated) 41
G2 (moderately differentiated) 46
G3 (poor differentiated) 137
Histological growth 
pattern
Expanding type 115
Infiltrative type 109
Lymphatic vessel 
infiltrate
Present 59
Absent 165
pN category pN0 55
pN1 87
pN2 49
pN3 33
Metastatic node 
ratio (%)
05 5
1–19 72
20–39 30
40–59 26
60–79 20
80–100 21BMC Cancer 2007, 7:200 http://www.biomedcentral.com/1471-2407/7/200
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Surgically dissection of lymph nodes
Lymph nodes were meticulously dissected from the
enbloc specimens, and the classification of the dissected
lymph nodes was determined by surgeons who reviewed
the excised specimens after surgery based on the Japanese
Classification of Gastric Carcinoma [5]. Then the resected
lymph nodes were sectioned and stained with hematoxy-
lin and eosin and examined for metastasis by patholo-
gists. Clinical and histopathologic data of each patient
were collected and recorded in a specifically designed data
collection form. From the 224 cases, a total of 6316
lymph nodes (range 15–75 per patient) were picked up
and histologically examined (Table 1).
Classification of lymphadenectomy
Based on the Japanese Classification of Gastric Carcinoma
(JCGC), lymph nodes were classified as Group 1 (the per-
igastric lymph nodes), Groups 2 (the lymph nodes along
the left gastric artery, the common hepatic artery, and the
splenic artery and around the celiac axis [5]. However,
when the tumor is located in the lower third stomach, the
lymph nodes along the splenic artery are classified as
being in Group 3) and Group 3 (lymph nodes in the hep-
atoduodenal ligament, at the posterior aspect of the head
of the pancreas, and at the root of the mesentery). Accord-
ingly, lymphadenectomy was classified as D1, dissection
of all the Group 1 lymph nodes; D2, dissection of all the
Group 1 and Group 2 lymph nodes; and D3, dissection of
all the Group 1, Group 2 and Group 3 lymph nodes.
pN category was defined as pN0 (no metastatic lymph
node), pN1 (1–6 metastatic lymph nodes), pN2 (7–15
metastatic lymph nodes) and pN3 (> 15 metastatic lymph
nodes), according to the 5th Edition of UICC [18]. The
metastatic lymph node ratio was calculated by dividing
the total number of lymph nodes that have been removed
and examined by the number of metastatic lymph nodes.
The ratio was rated in six grades, from 0 and to 100%,
with an increment of every 20% (Table 1).
The location of tumors was defined as upper, middle and
lower third gastric cancer, according to JCGC and the his-
tological type was defined as differentiated and undiffer-
entiated, according to UICC [5,18]. In addition,
histological growth patterns were also defined as expand-
ing and infiltrative types [19].
Statistical analysis
The correlation of the total number of dissected lymph
nodes with pN catergory and the metastatic lymph node
ratio was evaluated by curve fitting. We also examined the
functional form of the covariate under study by Kaplan-
Meier and Log rank test were adopted in the analysis of
survival rate comparison. Univariate analysis and Martin-
gale residual analysis were used to determine the associa-
tion between the metastatic lymph node ratio and
survival. Multivariate analysis was performed by using the
Cox proportional hazards model selected in forward step-
wise. All the data were analyzed with SPSS 13.0 statistics
software (Chicago, IL United States). A P value of less than
0.05 was considered statistically significant.
Results
Correlation of pN catergory and the metastatic lymph 
node ratio with the total number of dissected lymph nodes
The total number of metastatic nodes was significantly
influenced by the extension of the lymphadenectomy in
gastric cancer (F = 29.085, P = 0.000).
The curve of pN category and the metastatic node ratio
ascended while the number of total dissected nodes
increased. In addition, the curve of pN category increased
more significantly than metastatic node ratio category,
especially when the total number of the dissected nodes
was more than 25 (Figure 1).
Survival
The 5-year survivals were 78%, 61%, 25%, 0% in cases
with a metastastic node ratio of 0%, < 40%, 40–79, and ≥
80%, respectively (P < 0.00), and 78%, 62%, 38%, 0% in
cases with pN0, pN1, pN2, and pN3, respectively (P <
The correlation of pN category and the metastatic lymph  node ratio with the number of total resected lymph nodes Figure 1
The correlation of pN category and the metastatic 
lymph node ratio with the number of total resected 
lymph nodes. The cuvres of pN and the metastatic nodes 
ratio ascended while the total number of dissected nodes 
increased, with the cuvre of pN category increased more sig-
nificantly than metastatic node ratio, especially when the 
total number of the dissected nodes was more than 25.BMC Cancer 2007, 7:200 http://www.biomedcentral.com/1471-2407/7/200
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0.00). There was only a slight difference in the survival
rates between patients with pN0 and pN1 and between
those with a metastatic lymph node ratio of 0 and < 40%,
but the survival rates decreased significantly in other
groups (Figures 2 &3). Further analyses revealed that in
patients with a metastatic node ratio of 40–79% and cases
with the ratio of ≥ 80%, there was no significant difference
in survival among the patients with pN1, pN2 and pN3
(Figures 4 &5). However, in cases with pN3, there was a
significant difference in the survival rate among the
patients with a lymph node ratio of < 40%, 40–79% and
≥ 80%) (P = 1/20.025) (Figure 6), although this difference
was absent in patients with pN1 and pN2 (Figure 7).
Metastatic lymph node ratio as a prognostic risk factor
The relative risk showed an increasing value from 1.866 to
12.554 as the metastatic lymph node ratio group
increased (Table 2). Since the hazard ratios between cate-
gories 40–59% and 60–79%, and between 1–19% and
20–39% were very similar, the metastatic lymph node
ratio was re-rated into four different grades (0, < 40%, 40–
79 and ≥ 80%) (Table 2). The correlation between pN
stages and the ratio grades is shown in Table 3.
Multivariate analysis of prognostic factors
The total number of metastatic lymph nodes (with pN cat-
egory) and the metastatic lymph node ratio (with the 4-
grade category) were evaluated along with other potential
prognostic factors (including sex, age, the number of
tumor, maximum tumor diameter, pT category, location
Survival curve of cases with metastatic lymph node ratio 40– 79%, in relation to pN category Figure 4
Survival curve of cases with metastatic lymph node ratio 40–
79%, in relation to pN category. No significant difference was 
observed in cumulative survival rates after surgery among the 
groups (pN1, pN2 and pN3) (P = 0.367; Kaplan-Meier and 
log-rank test).
Survival curve and comparison of cumulative survival rates  after surgery according to the metastatic lymph node ratio,  calculated by dividing the total number of lymph nodes that  have been removed and examined by the number of meta- static lymph nodes (0%, < 40%, 40–79, and ≥ 80%) Figure 2
Survival curve and comparison of cumulative survival rates 
after surgery according to the metastatic lymph node ratio, 
calculated by dividing the total number of lymph nodes that 
have been removed and examined by the number of meta-
static lymph nodes (0%, < 40%, 40–79, and ≥ 80%). There 
were significant differences among the groups (P < 0.00; Kap-
lan-Meier and log-rank test).
Survival curve and comparison of cumulative survival rates  after surgery according to according to pN categories (pN0:  no metastatic lymph node, pN1: 1–6 metastatic lymph nodes,  pN2: 7–15 metastatic lymph nodes, and pN: > 15 metastatic  lymph nodes) Figure 3
Survival curve and comparison of cumulative survival rates 
after surgery according to according to pN categories (pN0: 
no metastatic lymph node, pN1: 1–6 metastatic lymph nodes, 
pN2: 7–15 metastatic lymph nodes, and pN: > 15 metastatic 
lymph nodes). There were significant differences among the 
groups (P < 0.00; Kaplan-Meier and log-rank test).BMC Cancer 2007, 7:200 http://www.biomedcentral.com/1471-2407/7/200
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of tumor, histological type, and histological growth pat-
tern and lymphatic vessel infiltrate) for the prognostic sig-
nificance in the multivariate analysis by using Cox
regression (Table 4).
The lymph node ratio category, the metastatic lymph
node ratio, age, the maximum tumor diameter, histologi-
cal type, were revealed to be independent prognostic fac-
tors, with the metastatic lymph node ratio being the most
significantly independent facror (Table 4).
Discussion
At present, the classification of metastatic lymph nodes in
gastric cancer is still under extensive evaluation and inves-
tigation. In Japan, the JCGC classification that is based on
the anatomical location of nodal involvement has been
widely used [5]. However, some onco-surgical scholars in
Western countries advocate that quantitative evaluation
based on the number of metastatic lymph nodes is more
predictive of patient survival than evaluation based on
anatomical lymphatic spread [20,21]. Furthermore, there
is no consensus on the number of lymph nodes to be dis-
sected and examined for accurate staging of gastric cancer.
In the western world, D1 (limited) lymph node dissection
is generally performed, and thus it is difficult to have
more than 15 nodes histologically examined for the cases.
This problem has been identified by Mullaney et al. [22],
who found that only 31% of cases with surgically resected
gastric cancer could be accurately assessed according to
the TNM system, suggesting the need of an improved of
nodal staging. In Japan and some other Asian countries,
Survival curve of cases with pN3, in relation to metastatic  lymph node ratio Figure 7
Survival curve of cases with pN3, in relation to metastatic 
lymph node ratio. There was a significant difference in cumu-
lative survival rates after surgery among the groups (< 40%, 
40–79, and ≥ 80%) (P = 0.025; Kaplan-Meier and log-rank 
test).
Survival curve of cases with metastatic lymph node ratio >  80%, in relation to pN category Figure 5
Survival curve of cases with metastatic lymph node ratio > 
80%, in relation to pN category. No significant difference was 
observed in cumulative survival rates after surgery between 
the two groups (pN2 and pN3) (P = 0.224; Kaplan-Meier and 
log-rank test).
Survival curve of cases with pN2, in relation to metastatic  lymph node ratio Figure 6
Survival curve of cases with pN2, in relation to metastatic 
lymph node ratio. No significant difference was observed in 
cumulative survival rates after surgery among the groups (< 
40%, 40–79, and ≥ 80%) (P = 0.606; Kaplan-Meier and log-
rank test).BMC Cancer 2007, 7:200 http://www.biomedcentral.com/1471-2407/7/200
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D2 (extensive) lymph node dissection is a standard proce-
dure for most cases, where more than 30 lymph nodes are
routinely resected and histologically examined [23-26].
Therefore, the pN category may be not suitable for the
cases from whom only a small number of nodes are
resected and examined. Moreover, it is unclear whether
the pN category could be influenced by the extension of
lymphadenectomy in gastric cancer, and whether the met-
astatic lymph node ratio may truly prevent the phenome-
non of stage migration, especially in Asian populations
such as in Chinese.
In the present study, the correlation between the number
of metastatic lymph nodes and the total number of dis-
sected lymph nodes were determined. We found that the
number of metastatic lymph nodes was influenced by the
total number of dissected nodes. Moreover, we also
observed that the pN category was influenced by the
extension of lymphadenectomy more significantly than
the metastatic node ratio. This observed phenomenon is
in agreement with those reported by some other investiga-
tors, and may be explained by the following factors: 1),
the number of picked up lymph nodes from the resected
specimen varies among surgeons or pathologists
expended different efforts [16,26]; 2) lymph nodes of
large size or those macroscopically suspected to be meta-
static were examined; and 3) the number of lymph nodes
in gastric cancer varies in a great range in different
patients, so the total number of examined nodes have
influence on pN category [1,9,10]. However, the influence
owing to the large range of total number could be reduced
by the ratio. Thus, the metastatic node ratio would
decrease, resulting in the induction of stage migration.
It has been previous suggested that the number of meta-
static lymph nodes is a prognostic factor for gastric cancer
[9-12]. Recent studies, most carried out in western popu-
lations, have demonstrated that metastatic lymph node
ratio is a more reliable prognostic factor [12,14-17,27]. In
this study of Chinese patients, we determined the survival
rates in patients with gastric cancer, according to the pN
catergory and metastatic lymph node ratio. We observed
there was no significant deference in the survival rates
between patients with pN0 and those with pN1 (pN cate-
gory) and between patients with 0% and those with <
40% (the metastatic lymph node ratio). Moreover, we
noticed that in patients with a metastatic node ratio of
40–79% and cases with the ratio of ≥ 80%, there was no
significant difference in survival rate among the patients
with pN1, pN2 and pN3. However, in cases with pN3,
there was a significant difference in the survival rate
among the patients with a lymph node ratio of < 40%,
40–79% and ≥ 80%, suggesting that the lymph node ratio
is a better prognostic indicator than pN category, at least
for cases with pN3.
Table 2: Univariate analysis of the metastatic lymph node ratio as a risk factor for survival
Metastatic lymph node ratio (%) Hazard ratio 95% confidence interval P value
Original grading 0
1–19 1.866 1.032–3.375 0.039
20–39 1.916 1.060–3.463 0.031
40–59 4.063 2.052–8.044 < 0.001
60–79 5.101 2.636–9.870 < 0.001
80–100 12.554 5.660–27.846 < 0.001
Revised grading 0
1–39 1.878 1.039–3.396 0.037
40–79 4.574 2.546–8.217 < 0.001
80–100 12.784 6.541–24.987 < 0.001
Table 3: Correlation between pN category and metastatic lymph node ratio
Metastatic lymph node ratio (%) Total number
0 1–39 40–79 80–100
pN category pN0 55 0 0 0 55
pN1 0 85 2 0 87
pN2 0 16 30 3 49
pN3 0 1 14 18 33
Total number 55 102 46 21 224BMC Cancer 2007, 7:200 http://www.biomedcentral.com/1471-2407/7/200
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Furthermore, we observed that hazard ratio in survival
analysis was increased from 1.878 to 12.784 in patients
with a metastatic lymph node ratio of 1–39%, 40–79%
and ≥ 80%. Multivariate analysis further identified that
the metastatic lymph node ratio was a most important
independent prognostic factor amongst the other factors
evaluated, including pN category. These findings empha-
size the importance of metastatic lymph node ratio, as a
reliable prognostic factor, to be included in a more accu-
rate lymph node classification system.
Conclusion
Lymph node ratio category has advantages in providing a
more precise prognostic value than the pN category(5th
edition, UICC). We recommend that classification of
nodal status be established by a combination of both the
metastatic nodes number and ratio, which would be the
best category to provide both rational lymph node dissec-
tion and the foundation for adjunctive therapy and pre-
dict the prognosis [15,27-29].
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